Locations
Irvine, CA, USA
industry
Biotechnology · DeepTech · Health
Size
201-1000 employees
Stage
Other
founded in
2017
Tarsus Pharmaceuticals is a biopharmaceutical company dedicated to creating innovative treatments for diseases with high unmet needs, particularly in eye care. Their lead product, XDEMVY® (lotilaner ophthalmic solution) 0.25%, is the first and only FDA-approved treatment for Demodex blepharitis, addressing a significant market gap. The company is also advancing a robust pipeline with investigational therapies for conditions like papulopustular rosacea and Lyme disease. Tarsus differentiates itself through its commitment to patient needs and a unique scientific approach, positioning itself strongly in the biopharmaceutical landscape.
Something looks off?On-site & Remote